Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections

NCT05893147 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.

NCT NCT05893147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05893147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
Lead sponsor
Sunnybrook Health Sciences Centre
Phase
Not applicable
Overall status
Completed
Start date
August 26, 2023
Completion date
August 10, 2024
Enrollment
174 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

gram-negative bacteremia